Company profile: List Labs
1.1 - Company Overview
Company description
- Provider of microbial CDMO services, offering end-to-end support from early-stage process development to cGMP manufacturing for Phase I & II clinical supply, and research reagents including nearly 100 bacterial toxins, polysaccharides, and antibodies. Also supplies anthrax (PA, EF, LF), botulinum, C. difficile (Toxin A/B), and cholera toxins, and specializes in native toxins, recombinant proteins, fermentation, and assay development.
Products and services
- Microbial CDMO Services: Engineers a cGMP-compliant, full-range program spanning early-stage process development through cGMP manufacturing for Phase I & II clinical supply in microbial systems
- Research Reagents: Produces a research-grade catalog of nearly 100 reagents, including bacterial toxins, polysaccharides, and antibodies, for laboratory research and assay development
- Anthrax Toxins: Supplies component-specific anthrax toxin materials—Protective Antigen (PA), Edema Factor (EF), and Lethal Factor (LF)—for research purposes
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to List Labs
SeqLL
HQ: United States
Website
- Description: Provider of molecule sequencing technology for research and healthcare communities.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full SeqLL company profile →
Standard BioTools
HQ: United States
Website
- Description: Provider of microfluidic-based chips and instrumentation for biological research as a biotech tools company.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Standard BioTools company profile →
Sartorius
HQ: Germany
Website
- Description: Provider of laboratory and process technologies and equipment for biopharmaceutical production and laboratory environments, offering bioprocess solutions including filtration, fermentation, and purification technologies, and lab products and services with instruments and consumables for research and quality control, helping develop and manufacture biotech medicines reliably, quickly, and economically.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Sartorius company profile →
Newomics
HQ: United States
Website
- Description: Provider of integrative platforms for personalized healthcare, offering mass spectrometry and LC-MS solutions including DuoESI Source (dual ion source enhancing ionization for multiomics, compatible with leading mass spectrometers), MEA Chip (silicon LC column/ESI emitter/post-column inlet chip for improved sensitivity and robustness in proteomics), and M3 Emitter (silicon microfluidic flow-splitting emitter for enhanced ionization).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Newomics company profile →
JEOL
HQ: United States
Website
- Description: Provider of SEM and TEM (including cryo-EM) for high-resolution imaging and analysis, mass spectrometers for protein characterization, pharmaceuticals and high-throughput screening, NMR spectrometers for molecular structure analysis, EPMA for elemental analysis and high spatial resolution imaging, and FIB systems for sample preparation, imaging and analysis; based in Peabody.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full JEOL company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for List Labs
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to List Labs
2.2 - Growth funds investing in similar companies to List Labs
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for List Labs
4.2 - Public trading comparable groups for List Labs
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →